Skip to main navigation Skip to search Skip to main content

Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology

  • Caetano Reis e Sousa
  • , George Yap
  • , Oliver Schulz
  • , Neil Rogers
  • , Marco Schito
  • , Julio Aliberti
  • , Sara Hieny
  • , Alan Sher

Research output: Contribution to journal › Article › peer-review

Abstract

Interleukin-12 plays a major role in immunity to intracellular pathogens by governing the development of IFNγ-dependent host resistance. Nevertheless, unregulated IL-12 synthesis can lead to immunopathology, an outcome prevented by the concurrent expression of interleukin-10. Dendritic cells (DC) are an important source of the initial IL-12 stimulated by microbial agents. Here, we show that, following systemic triggering, DC can no longer be restimulated to produce IL-12 in vivo while continuing to respond in vitro. When infected with Toxoplasma gondii during this refractory state, mice mount impaired acute IFNγ responses and, in the case of IL-10- deficient animals, are protected from cytokine-induced mortality. These findings demonstrate a previously unrecognized form of immunologic paralysis involving DC that can protect from infection-induced immunopathology.

Original languageEnglish (US)
Pages (from-to)637-647
Number of pages11
JournalImmunity
Volume11
Issue number5
DOIs
StatePublished - Nov 1999
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology'. Together they form a unique fingerprint.

Cite this